Can cefaclor capsules cure mycoplasma infection

Cefaclor Capsule (Meiyou) is a prescription drug, developed and produced by Shanghai Meiyou Pharmaceutical Co., Ltd., which is mainly suitable for respiratory system, urinary system, otolaryngology, skin and soft tissue infections caused by sensitive bacteria.There are good results. So can cefaclor capsules cure mycoplasma infection

Cefaclor capsules are not used to treat mycoplasma infection, which is only effective against certain susceptible strains and not for disease caused by mycoplasma infection.

The antibacterial performance of cefaclor is similar to that of cefazolin, and has good antibacterial effect on staphylococci (including enzyme-producing strains), Streptococcus pyogenes, pneumococcus, Escherichia coli, Proteus mirabilis, Haemophilus influenzae, etc.

Cefaclor is used orally, taking 0.25, 0.5 or 1g on an empty stomach, and the peak blood drug concentration is 7, 13 or 23 μg/ml within 30~60 minutes, respectively. It is mainly distributed in blood, internal organs, and skin tissues. Low concentrations in brain tissue. The half-life is 0.6~0.9 hours, the drug is excreted by the urine, 0.25g orally at a time, the peak concentration of urine can reach 600μg/ml, and the half-life of renal insufficiency is slightly prolonged.

Cefaclor is a second-generation oral cephalosporin, which has stronger antibacterial effect than cefadroxil, and has the same activity against group A hemolytic streptococcus, viridans streptococcus and Staphylococcus epidermidis as cefadroxil. The antibacterial activity against pneumococcus and non-enzyme-producing Staphylococcus aureus was 2~4 times stronger than that of cefadroxil, and the activity against enzyme-producing Staphylococcus aureus was the same.

The activity of cefaclor against Escherichia coli and pneumobacterium is similar to that of cefadroxil; However, the activity against Proteus mirabilis was significantly stronger than that of cefadroxil, with a MIC90 of 1.82 mg/L. The MIC for Salmonella and Shigella was 0.25~1mg/L, which was 8 times stronger than that of cefadroxil, and the MIC for gonorrhoea was 0.016~1mg/L. Many β-producing lactamase-producing influenza bacilli are sensitive to cefaclor; Most Proteus vulgaris, Serratia, Acinitobacter spp., and Pseudomonas aeruginosa are resistant to cefaclor.